Suggestions appear as you type. Use the up and down arrows to choose one and Enter to open it.

This page's audience our own tag's counts — open to see them
–Visits
–Page views
–Clicks to vendors
–Time on page
–Reading now
Clicks to vendors, by tool
  • –
Top countries
  • –
Devices
  • –

– · visits, page views and clicks counted by our own tag, which counts more than our checked analytics; every figure rounded down · how we count

Head-to-head · AI Drug Discovery Software

Recursion vs XtalPi ID4Inno

  • Updated Oct 2026
  • Both researched from official sources
  • 4 checks side by side
Higher score Recursion #3 in AI Drug Discovery Software 8.7/10 Pricing on request ✓ 3 of 4 features Visit Recursion
XtalPi ID4Inno #6 in AI Drug Discovery Software 7.8/10 Pricing on request ✓ 2 of 4 features Contact XtalPi

Recursion leads on 0 checks, XtalPi ID4Inno on 0, and 4 are even. Who comes out ahead on the 4 yes/no, price and count checks where we have data for both products. The editor score weighs everything else too.

Our verdict

  • Highest scoreRecursion · 8.7/10
  • Most featuresRecursion · 3 of 4

Recursion scores higher on our rubric for ai drug discovery software: 8.7 against 7.8 out of 10; our editors rank them #3 and #6.

Recursion is the better fit for teams linking computational discovery to experiments. XtalPi ID4Inno is the better fit for teams advancing hits through computational and lab cycles.

  • Recursion fits best

    Teams linking computational discovery to experiments

  • XtalPi ID4Inno fits best

    Teams advancing hits through computational and lab cycles

Advertiser disclosure: iTechGuides is reader-supported. Vendors can pay for top positions in our rankings and for a place on other products' pages, and we may earn a commission when you click some links. Bought places stand at the number bought; this page and our disclosure say so. Paying vendors may get a fuller, more detailed review from our editors, and that review can change their score. How we rank.

Side by side

Feature Recursion 8.7/10 Visit ↗ XtalPi ID4Inno 7.8/10 Visit ↗
At a glance
Editor score 8.7 7.8
Ranking #3 in AI Drug Discovery Software #6 in AI Drug Discovery Software
Best for Teams linking computational discovery to experiments Teams advancing hits through computational and lab cycles
Pricing model Paid Paid
Starting price Pricing on request Pricing on request
Free plan — Not checked yet
Free trial — —
Built for Mid-market, Enterprise Mid-market, Enterprise
Features Recursion 3/4 · XtalPi ID4Inno 2/4
Target identification ✓ (best) Not checked yet
Molecule design ✓ ✓
Drug repurposing Not checked yet Not checked yet
Research publications ✓ ✓
Specs
Discovery scope Suite Suite
Deployment options Not checked yet Cloud
Our review
Pros
  • Connects target identification, molecule design and ADMET computation.
  • Combines machine-learning analysis of biological and chemical data.
  • Schedules synthesis and experiments, with results feeding computational workflows.
  • Combines goal-directed molecule generation with property optimization.
  • Supports virtual screening, induced-fit docking, and binding free-energy prediction.
  • Connects computational workflows with automated synthesis and experimental feedback.
Cons
  • No free plan is available.
  • Pricing is handled through sales rather than public plan tiers.
  • The proprietary Recursion OS is not open source.
  • Focused on small-molecule discovery rather than broader modalities.
  • Cloud deployment may not suit teams seeking on-premises deployment.
  • Pricing is handled through sales rather than self-serve plans.
Our verdict

Recursion OS brings computational drug discovery and physical experimentation into one platform, with workflows that span target identification through molecule design and onward into development. Its capabilities include machine-learning…

Read the review →

XtalPi ID4Inno is a cloud-based small-molecule drug discovery platform for pharmaceutical and biotech research teams working on hit discovery and lead optimization, including projects against nominated targets. It brings AI-based molecule…

Read the review →
  1. RecursionAI Drug Discovery Software 8.7Pricing on request
  2. XtalPi ID4InnoAI Drug Discovery Software 7.8Pricing on request

Strengths and trade-offs

  • Recursion — where it wins

    • Connects target identification, molecule design and ADMET computation.
    • Combines machine-learning analysis of biological and chemical data.
    • Schedules synthesis and experiments, with results feeding computational workflows.

    Where it doesn't

    • No free plan is available.
    • Pricing is handled through sales rather than public plan tiers.
    • The proprietary Recursion OS is not open source.
  • XtalPi ID4Inno — where it wins

    • Combines goal-directed molecule generation with property optimization.
    • Supports virtual screening, induced-fit docking, and binding free-energy prediction.
    • Connects computational workflows with automated synthesis and experimental feedback.

    Where it doesn't

    • Focused on small-molecule discovery rather than broader modalities.
    • Cloud deployment may not suit teams seeking on-premises deployment.
    • Pricing is handled through sales rather than self-serve plans.
  • Recursion8.7/10 · Pricing on request

    A broad discovery suite for teams connecting computational models with lab experiments.

    Visit RecursionFull verdict →
  • XtalPi ID4Inno7.8/10 · Pricing on request

    A cloud discovery suite linking molecule design, computational screening, and experimental feedback.

    Contact XtalPiFull verdict →

More comparisons

Guides on AI drug discovery software

Reviewed by iTechGuides Editors · Editorial team · Updated Oct 2026

Last updated · How we research and update